Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

AdaptHealth (AHCO) EBIAT (2018 - 2025)

AdaptHealth has reported EBIAT over the past 8 years, most recently at -$98.0 million for Q4 2025.

  • Quarterly results put EBIAT at -$98.0 million for Q4 2025, down 308.34% from a year ago — trailing twelve months through Dec 2025 was -$63.8 million (down 170.51% YoY), and the annual figure for FY2025 was -$66.0 million, down 173.03%.
  • EBIAT for Q4 2025 was -$98.0 million at AdaptHealth, down from $24.5 million in the prior quarter.
  • Over the last five years, EBIAT for AHCO hit a ceiling of $80.1 million in Q2 2021 and a floor of -$454.1 million in Q3 2023.
  • Median EBIAT over the past 5 years was $16.3 million (2023), compared with a mean of -$20.7 million.
  • Biggest five-year swings in EBIAT: soared 1259.53% in 2022 and later plummeted 15838.13% in 2023.
  • AdaptHealth's EBIAT stood at $24.9 million in 2021, then plummeted by 106.3% to -$1.6 million in 2022, then plummeted by 15838.13% to -$250.4 million in 2023, then soared by 118.79% to $47.0 million in 2024, then plummeted by 308.34% to -$98.0 million in 2025.
  • The last three reported values for EBIAT were -$98.0 million (Q4 2025), $24.5 million (Q3 2025), and $15.8 million (Q2 2025) per Business Quant data.